This product is a histamine H2 receptor blocker. It has a significant inhibitory effect on gastric acid secretion, and can also inhibit the secretion of pepsin, and has a certain protective effect on animal experimental ulcers. It takes effect about 1 hour after taking the medicine, and the effect can last for more than 12 hours.

Extract from the above information

The specific pharmacological effect is not clear from the above information

Selective 5-hydroxytryptamine 3 (5-HT3) receptor antagonists block the vomiting reflex caused by chemotherapy and surgery that promotes the release of 5-hydroxytryptamine from intestinal chromaffin cells and excites vagal afferent nerves by antagonizing 5-HT3 receptors in peripheral vagal nerve endings and central chemoreceptor areas. It has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

Inhibition of bone resorption may be related to multiple effects, including inhibition of osteoclast activity, induction of osteoclast apoptosis, blocking osteoclast resorption of mineralized bone and cartilage by binding to bone, and inhibition of enhanced osteoclast activity and bone calcium release caused by various stimulating factors released by tumors.